United States · FDA National Drug Code directory
Hetlioz LQ
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43068-304_8463c372-11ff-4caf-ad72-54d54a4a795d
- Product NDC
- 43068-304
- Form
- SUSPENSION
- Composition / generic term
- tasimelteon
- Labeler
- Vanda Pharmaceuticals Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20201210
- Source listing expiry
- 20271231
Source-listed ingredients
- TASIMELTEON — 4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (43068-304-02) / 48 mL in 1 BOTTLE · 43068-304-02
- 1 BOTTLE in 1 CARTON (43068-304-06) / 158 mL in 1 BOTTLE · 43068-304-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →